Analysts Are Updating Their Viscofan, S.A. (BME:VIS) Estimates After Its Yearly Results

The full-year results for Viscofan, S.A. (BME:VIS) were released last week, making it a good time to revisit its performance. It was an okay result overall, with revenues coming in at €1.2b, roughly what the analysts had been expecting. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Viscofan after the latest results.

See our latest analysis for Viscofan

After the latest results, the ten analysts covering Viscofan are now predicting revenues of €1.28b in 2025. If met, this would reflect a satisfactory 5.0% improvement in revenue compared to the last 12 months. Yet prior to the latest earnings, the analysts had been anticipated revenues of €1.28b and earnings per share (EPS) of €3.71 in 2025. Overall, while the analysts have reconfirmed their revenue estimates, the consensus now no longer provides an EPS estimate. This implies that the market believes revenue is more important after these latest results.

We'd also point out that thatthe analysts have made no major changes to their price target of €72.40. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Viscofan at €79.00 per share, while the most bearish prices it at €63.00. This is a very narrow spread of estimates, implying either that Viscofan is an easy company to value, or - more likely - the analysts are relying heavily on some key assumptions.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We would highlight that Viscofan's revenue growth is expected to slow, with the forecast 5.0% annualised growth rate until the end of 2025 being well below the historical 8.6% p.a. growth over the last five years. Compare this to the 5 other companies in this industry with analyst coverage, which are forecast to grow their revenue at 4.3% per year. So it's pretty clear that, while Viscofan's revenue growth is expected to slow, it's expected to grow roughly in line with the industry.

The Bottom Line

The clear take away from these updates is that the analysts made no change to their revenue estimates for next year, with the business apparently performing in line with their models. Happily, there were no real changes to revenue forecasts, with the business still expected to grow in line with the overall industry. The consensus price target held steady at €72.40, with the latest estimates not enough to have an impact on their price targets.

We have estimates for Viscofan from its ten analysts out to 2027, and you can see them free on our platform here.

Plus, you should also learn about the 1 warning sign we've spotted with Viscofan .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.